Taking an inclusive approach to combine both datasets, we identified 293 and 7390 differentially expressed genes between MYC-high and MYC-low prostate tumors in the LCM tissue and TCGA PRAD cohorts, respectively (Fig. 2d, e) that were concordantly regulated in the same direction. The gene discussed is MYC; the disease is prostate adenocarcinoma.